NNE
Fiscal year ends September Quarters are offset from the calendar — Q1 is Oct–Dec

Nano Nuclear Energy Inc. is a nuclear energy and technology company developing advanced clean energy solutions, including microreactors, nuclear fuel fabrication, and transportation services. The company focuses on five business lines: portable and stationary microreactor technologies, nuclear fuel fabrication, nuclear fuel transportation, nuclear applications for space, and nuclear industry consulting. Its principal products include the KRONOS MMR Energy System, a high-temperature gas-cooled reactor; the LOKI MMR, a portable reactor; and the ZEUS reactor, a solid core battery reactor. The company also holds rights to the ODIN reactor. Through its subsidiary True North Nuclear Inc., it advances the KRONOS MMR project in Canada, including a demonstration project at Chalk River Laboratories. Advanced Fuel Transportation Inc. provides HALEU fuel transportation services, while HALEU Energy Fuel Inc. focuses on domestic HALEU fuel fabrication. Nano Nuclear Space Inc. explores commercial applications of its reactor technology for space missions. The company acquired key assets from Ultra Safe Nuclear Corporation in 2025 and is in the pre-revenue stage, targeting commercial launch in the 2030s.

Summarised from the company's own disclosures, fiscal year ended Dec 2025

Industry Oil & Gas E&P Homepage nanonuclearenergy.com
Sector Energy IR page nanonuclearenergy.com/nano-nuclear-announces-participation-in-several-investor-conferences
Tags
nuclear microreactors, high-temperature gas-cooled reactors, haleu fuel, nuclear fuel transportation, space nuclear power, modular reactors, triso fuel, nuclear consulting, KRONOS MMR Energy System, LOKI MMR, ZEUS, ODIN, True North Nuclear Inc., Advanced Fuel Transportation Inc., HALEU Energy Fuel Inc., Nano Nuclear Space Inc., Kronos MMR Inc., Global First Power Ltd.
Press page —

Metrics

Valuation  
Market cap $ 851.116M
Market cap (USD) $ 851.116M
P/E -22.32
PEG —
P/BV 1.38
P/S —
P/OCF -36.11
P/FCF -30.32
Dividend yield —
Turnover / mcap —
Returns  
ROE -31.5%
ROI -185.8%
ROIC -156.5%
Profit margin —
Growth  
Revenue growing —
Profits growing No
Revenue up 3y —
Revenue up 5y —
Earnings growth 3y (net profit CAGR) —
Quality  
Profitable No
Margin expanding —
Buying back stock No
Diluting (TTM) Yes
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 65
Quality score -61.5%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022
Assets 228.657M 35.096M 7.234M 2.247M
Net profit -40.067M -10.152M -6.25M 0
Free cash flow -28.071M -10.164M -3.868M —

Figure FY 2025 FY 2024 FY 2023 FY 2022
Share price 38.56 14.41 — —
Price performance 12m 1.68 — — —

Filed figures

Figure Sep 2023 Sep 2024 Sep 2025
Balance sheet detail
Trade receivables (USD) — — 250,000
Lease liabilities (USD) — 1.93M 2.8M
Cash and deposits (USD) — 28.5M 203M
Right-of-use assets (USD) — 1.83M 2.56M
Cash flow detail
Operating cash flow (USD) 3.87M -8.46M -19.6M
Purchases of property, plant and equipment (USD) — -1.7M -8.45M
Change in receivables (cash effect) (USD) — — -250,000
Change in payables (cash effect) (USD) 87,234 571,474 553,115
Share-based compensation (USD) 2.38M 320,257 18.8M
Operating cash flow before change in receivables (USD) — — -19.4M
Free cash flow (OCF - PPE - intangibles) (USD) — -10.2M -28.1M
Income detail
Research and development expense (USD) 1.53M 3.73M 15.4M
Reported Dec 30, 2024 Feb 13, 2025 May 14, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

October 29, 2026

PDF Version

STS’ long-standing radiological security partnership with NNSA/Y-12 advances U.S. national security objectives while helping preserve critical medical capabilities for international partners

New York, N.Y., Oct. 29, 2026 (GLOBE NEWSWIRE) -- NANO Nuclear Energy Inc. (NASDAQ: NNE) ("NANO Nuclear" or “the Company"), a leading advanced nuclear micro modular reactor and technology company developing microreactors, nuclear fuel cycle capabilities and nuclear transportation solutions, alongside Secured Transportation Services (STS), a wholly owned subsidiary, today announced its role in the successful removal and secure transportation of a vulnerable cesium-137 (Cs-137) radioactive source from the Fundação Hospitalar de Hematologia e Hemoterapia do Amazonas (HEMOAM) in Manaus, Brazil.

The September 2, 2026 operation was conducted in support of the U.S. Department of Energy’s National Nuclear Security Administration’s (NNSA) Office of Radiological Security (ORS) and managed by the Y-12 National Security Complex (Y-12). STS served as the lead subcontractor responsible for execution of the planning, logistics and removal activities, working closely with Y-12, Brazilian radiological experts, regulatory authorities, transportation providers, security personnel, and other project partners.

The project represents the latest achievement in a long-standing effort to reduce the security risks associated with high-activity radioactive sources while ensuring that important medical capabilities remain available to the communities that depend on them. HEMOAM had historically relied on a Gammacell 3000 blood irradiator containing a Cs-137 radioactive source. Through NNSA’s Alternative Technologies initiative, the facility transitioned to an X-ray blood irradiation system that allows it to maintain critical blood irradiation capabilities without continued reliance on the high-activity radioactive source.

“This project represents exactly what can be accomplished when national security expertise, technical capability and strong international partnerships come together around a shared mission,” said Roy A. Boyd II, President of Secured Transportation Services. “For STS, the mission extends beyond safely moving radioactive material. It is about applying decades of specialized experience to help the United States and our international partners reduce radiological risk while ensuring that essential medical capabilities remain available to the people who depend on them.”

The Manaus operation required extensive planning and coordination to safely remove the source from a working medical facility and transport it across one of Brazil’s most geographically challenging regions. The source was transported by aircraft out of the remote Manaus region to an area with an established road network, where it was transferred to ground transportation for the final leg of its journey to a secure storage facility.

Following removal, the Cs-137 source was secured in a certified Type B(U) shipping container for transport. Under the oversight of Brazil’s Autoridade Nacional de Segurança Nuclear (ANSN), STS and Y-12 personnel worked with Brazilian partners to maintain positive control of the source and continuity of custody throughout the entire operation.

The HEMOAM operation marks the eighth radioactive-source removal completed in Brazil through this series of NNSA-ORS activities since 2023. Across these missions, Y-12 has managed the removal operations, with STS supporting preplanning, specialized field execution, and transportation in coordination with Brazilian experts and authorities.

“Successful projects like this are built over years, not days,” Boyd added. “They depend on trusted relationships, disciplined planning, and people who understand that safety and security cannot be compromised. We are proud of the STS team and proud to continue supporting Y-12 and NNSA in a mission that strengthens the security of the United States while providing meaningful benefits to our international partners.”

The Brazil program demonstrates the broader value of U.S. leadership in radiological security. By helping partner nations transition away from vulnerable high-activity radioactive sources where appropriate, these efforts reduce the potential for radioactive material to be lost, stolen, or used for malicious purposes while supporting the continued availability of technologies essential to healthcare and other peaceful applications.

For STS, the successful Manaus operation also reflects more than two decades of experience supporting complex nuclear and radiological transportation missions where safety, security, regulatory compliance, and operational execution are paramount.

About NANO Nuclear Energy, Inc.

**NANO Nuclear Energy Inc. (NASDAQ: NNE)**is a North American advanced technology-driven nuclear energy company seeking to become a commercially focused, diversified, and vertically integrated company across three primary business lines: (i) cutting edge microreactor technologies, (ii) nuclear fuel supply chain, (iii) nuclear fuel transportation..

Led by a world-class nuclear engineering team, NANO Nuclear’s flagship microreactor under development is the proprietary KRONOS MMR**™**Energy System, a stationary high-temperature gas-cooled reactor that’s advancing through the formal U.S. Nuclear Regulatory Commission (NRC) licensing process following the University of Illinois Urbana-Champaign’s construction permit application submission for the deployment of the microreactor at the university.

Advanced Fuel Transportation Inc. (AFT), a NANO Nuclear subsidiary, bolstered by the May 2026 acquisition of Secured Transportation Services (STS), is the exclusive licensee of a patented high-capacity HALEU fuel transportation basket developed by three major U.S. national nuclear laboratories and funded by the Department of Energy. STS provides specialized transportation, logistics, project management, and technical services supporting the nuclear and radiological industries. STS brings decades of experience executing complex missions involving radioactive and other sensitive materials, with an emphasis on safety, security, regulatory compliance, and mission assurance.

Through its work with U.S. government agencies, national security partners, commercial organizations and international stakeholders, STS supports the safe and secure movement and management of nuclear and radiological materials in furtherance of U.S. national security, nonproliferation, and peaceful-use objectives.

HALEU Energy Fuel Inc. (HEF), a NANO Nuclear subsidiary, is focusing on the future development of a domestic source for a High-Assay, Low-Enriched Uranium (HALEU) fuel fabrication pipeline for NANO Nuclear’s own microreactors as well as the broader advanced nuclear reactor industry.

For more corporate information please visit: https://NanoNuclearEnergy.com/

For further NANO Nuclear information, please contact: Email: [email protected] Business Tel: (212) 634-9206

PLEASE FOLLOW OUR SOCIAL MEDIA PAGES HERE: NANO Nuclear Energy LINKEDIN NANO Nuclear Energy YOUTUBE NANO Nuclear Energy X PLATFORM

Cautionary Note Regarding Forward Looking Statements

This news release and statements of NANO Nuclear's management and collaborators in connection with this news release contain or may contain "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. In this context, forward-looking statements mean statements related to future events, which may impact our expected future business and financial performance, and often contain words such as "expects", "anticipates", "intends", "explore", "plans", "aim", "goal", "believes", "potential", "future", "will", "should", "could", "would" or "may" or derivations of these words and other words of similar meaning about the future. In this press release, forward-looking statements include those relating to STS’ specialized nuclear transportation capabilities, STS’ customers and contacts, and their potential contribution to NANO Nuclear’s overall strategy and results of operations. These and other forward-looking statements are based on information available to us as of the date of this news release and represent management's current views and assumptions. Forward-looking statements are not guarantees of future performance, events or results and involve significant known and unknown risks, uncertainties and other factors, which may be beyond our control. For NANO Nuclear, particular risks and uncertainties that could cause our actual future results to differ materially from those expressed in our forward-looking statements include but are not limited to: (i) risks related to our U.S. Department of Energy ("DOE"), U.S. Nuclear Regulatory Commission ("NRC"), Canadian Nuclear Safety Commission ("CNSC") or related state or other U.S. or non-U.S. nuclear licensing submissions; (ii) risks related to the development of new or advanced technology and the acquisition or integration of complementary technology or businesses, including difficulties with design and testing, cost overruns, regulatory delays, integration issues, the development of competitive technology and the ability to generate revenue from acquired or development businesses and technologies; (iii) our ability to obtain and maintain key vendor, technology, project, financing and customer relationships and the significant funding necessary to execute on our business plan; (iv) uncertainty regarding our ability to technologically develop, license, manufacture and commercially deploy a competitive advanced nuclear reactor or other technology in the timelines we anticipate, if ever; (v) risks related to government regulation, policy, public procurement, export controls, supply-chain requirements and licensing requirements; and (vi) similar risks and uncertainties associated with operating a developing business in a highly regulated, competitive and rapidly evolving industry, including that our plans may change and we may use our cash on hand faster or in different ways than anticipated as our business requires. Readers are cautioned not to place undue reliance on these forward-looking statements, which apply only as of the date of this news release. These factors may not constitute all factors that could cause actual results to differ from those discussed in any forward-looking statement, and NANO Nuclear therefore encourages investors to review other factors that may affect future results in its filings with the SEC, which are available for review at www.sec.gov and at https://ir.nanonuclearenergy.com/financial-information/sec-filings. Accordingly, forward-looking statements should not be relied upon as a predictor of actual results. We do not undertake to update our forward-looking statements to reflect events or circumstances that may arise after the date of this news release, except as required by law.

Primary Logo

Search Investors

STS’ long-standing radiological security partnership with NNSA/Y-12 advances U.S. national security objectives while helping preserve critical medical capabilities for international partners

New York, N.Y., Oct. 29, 2026 (GLOBE NEWSWIRE) -- NANO Nuclear Energy Inc. (NASDAQ: NNE) ("NANO Nuclear" or “the Company"), a leading advanced nuclear micro modular reactor and technology company developing microreactors, nuclear fuel cycle capabilities and nuclear transportation solutions, alongside Secured Transportation Services (STS), a wholly owned subsidiary, today announced its role in the successful removal and secure transportation of a vulnerable cesium-137 (Cs-137) radioactive source from the Fundação Hospitalar de Hematologia e Hemoterapia do Amazonas (HEMOAM) in Manaus, Brazil.

The September 2, 2026 operation was conducted in support of the U.S. Department of Energy’s National Nuclear Security Administration’s (NNSA) Office of Radiological Security (ORS) and managed by the Y-12 National Security Complex (Y-12). STS served as the lead subcontractor responsible for execution of the planning, logistics and removal activities, working closely with Y-12, Brazilian radiological experts, regulatory authorities, transportation providers, security personnel, and other project partners.

The project represents the latest achievement in a long-standing effort to reduce the security risks associated with high-activity radioactive sources while ensuring that important medical capabilities remain available to the communities that depend on them. HEMOAM had historically relied on a Gammacell 3000 blood irradiator containing a Cs-137 radioactive source. Through NNSA’s Alternative Technologies initiative, the facility transitioned to an X-ray blood irradiation system that allows it to maintain critical blood irradiation capabilities without continued reliance on the high-activity radioactive source.

“This project represents exactly what can be accomplished when national security expertise, technical capability and strong international partnerships come together around a shared mission,” said Roy A. Boyd II, President of Secured Transportation Services. “For STS, the mission extends beyond safely moving radioactive material. It is about applying decades of specialized experience to help the United States and our international partners reduce radiological risk while ensuring that essential medical capabilities remain available to the people who depend on them.”

The Manaus operation required extensive planning and coordination to safely remove the source from a working medical facility and transport it across one of Brazil’s most geographically challenging regions. The source was transported by aircraft out of the remote Manaus region to an area with an established road network, where it was transferred to ground transportation for the final leg of its journey to a secure storage facility.

Following removal, the Cs-137 source was secured in a certified Type B(U) shipping container for transport. Under the oversight of Brazil’s Autoridade Nacional de Segurança Nuclear (ANSN), STS and Y-12 personnel worked with Brazilian partners to maintain positive control of the source and continuity of custody throughout the entire operation.

The HEMOAM operation marks the eighth radioactive-source removal completed in Brazil through this series of NNSA-ORS activities since 2023. Across these missions, Y-12 has managed the removal operations, with STS supporting preplanning, specialized field execution, and transportation in coordination with Brazilian experts and authorities.

“Successful projects like this are built over years, not days,” Boyd added. “They depend on trusted relationships, disciplined planning, and people who understand that safety and security cannot be compromised. We are proud of the STS team and proud to continue supporting Y-12 and NNSA in a mission that strengthens the security of the United States while providing meaningful benefits to our international partners.”

The Brazil program demonstrates the broader value of U.S. leadership in radiological security. By helping partner nations transition away from vulnerable high-activity radioactive sources where appropriate, these efforts reduce the potential for radioactive material to be lost, stolen, or used for malicious purposes while supporting the continued availability of technologies essential to healthcare and other peaceful applications.

For STS, the successful Manaus operation also reflects more than two decades of experience supporting complex nuclear and radiological transportation missions where safety, security, regulatory compliance, and operational execution are paramount.

For Full Official Press Release Press Here

← previous post

NANO Nuclear Energy Inc. (NASDAQ: NNE) is an advanced technology-driven nuclear energy company seeking to become a commercially focused, diversified, and vertically integrated company across the following business lines: (i) cutting edge portable and stationary microreactor technologies, (ii) nuclear fuel fabrication, (iii) nuclear fuel transportation, (iv) nuclear applications for space, and (v) nuclear industry consulting services. NANO Nuclear believes it is the first nuclear microreactor company to be listed publicly in the U.S.

Led by a world-class nuclear engineering team, NANO Nuclear’s reactor products in development include its lead technology, the patented KRONOS MMR™ Energy System, a stationary high-temperature gas-cooled reactor that is in construction permit pre-application with the U.S. Nuclear Regulatory Commission (NRC), ZEUS™, a solid core battery reactor, and the space-capable, portable LOKI MMR™, each representing advanced developments in clean energy solutions that are modular, on-demand capable, advanced nuclear microreactors.

Our Subsidiaries:

True North Nuclear Inc.

STS Nuclear

Annular Linear Induction Pumps

NANO Nuclear Space Inc.

Advanced Fuel Transportation Inc.

HALEU Energy Fuel Inc.

Important Links

About Us

Microreactors

Company Leadership

Board Members

Company News

In the Media

Investors

Press Kit

October 27, 2026

PDF Version

Collaboration brings the potential for engineering, procurement, construction, modularization and supply-chain capabilities into NANO Nuclear's platform as the University of Illinois KRONOS MMR™ project advances through NRC review

Framework creates a pathway from first-of-a-kind project planning to potential A/E, EPC, fabrication, U.S. manufacturing and future fleet-deployment support

New York, N.Y. and Seoul, Republic of Korea, Oct. 27, 2026 (GLOBE NEWSWIRE) -- NANO Nuclear Energy Inc. (NASDAQ: NNE) ("NANO Nuclear" or the "Company"),an advanced nuclear energy and technology company developing microreactors, nuclear fuel cycle capabilities and nuclear transportation solutions, today announced that it has signed a Memorandum of Understanding ("MOU") with Hyundai Engineering Co., Ltd. ("HEC") to establish a framework for potential collaboration to advance the KRONOS MMR™ Energy System project at the University of Illinois Urbana-Champaign ("U. of I.") and to evaluate broader cooperation on future NANO Nuclear manufacturing and deployment activities.

The MOU brings together NANO Nuclear's advanced reactor development program with HEC's engineering, procurement, construction, project-management, supply-chain, modularization, logistics and industrial-project capabilities. The parties initially intend to focus on project-execution planning, conventional and site-related work, procurement readiness, constructability, modularization, logistics, supply-chain development and U.S. localization planning for the U. of I. project, while preserving clear interfaces with the U. of I., existing expected contractors and applicable public-procurement requirements.

The collaboration is designed to give NANO Nuclear a structured pathway to bring experienced project-execution capability into the KRONOS MMR**™** project at an increasingly important stage of development. Subject to technical and commercial evaluation, availability of scope, U. of I. and regulatory requirements and separate definitive agreements, the parties may later expand HEC's role to include architecture and engineering ("A/E"), engineering and procurement ("EP"), engineering, procurement and construction ("EPC"), construction management, equipment or component fabrication, and support for future KRONOS MMR™ reactor fleet deployment.

Figure 1: NANO Nuclear Energy Inc. Signs MOU with Hyundai Engineering Co., Ltd. to establish a framework for future collaboration

Building an Industrial Project-Execution Platform Around the KRONOS MMR**™**System

NANO Nuclear and HEC expect to designate a working team and begin preparing a preliminary responsibility and interface matrix. That work is intended to define potential project packages, clarify design and procurement interfaces, identify presently unassigned work for the project, and establish a disciplined basis for future contracting as the U. of I. project progresses.

Anticipated workstreams identified in the MOU include conventional facility constructability and modularization studies; construction sequencing and site mobilization; civil and site packages; supplier identification and prequalification; long-lead-item planning; U.S. and Korean supplier mapping; domestic-content and localization planning; heavy-haul and construction logistics; commissioning and turnover support; and procurement-readiness, cost and schedule benchmarking. Any compensated scope would be implemented under a separate definitive agreement with the appropriate contracting parties.

The MOU also contemplates future cooperation on U.S. reactor-component and core-manufacturing facility planning, modular-factory and production-line development, standardization and replication for future KRONOS MMR**™** system deployments, U.S.-Korea supplier-development initiatives, and potential financing, export-credit, insurance and industrial-participation pathways. These areas are intended to help NANO Nuclear build not only a first deployment at the U. of I., but the industrial infrastructure and a repeatable project model required for a future commercial fleet.

The collaboration also builds on more than a decade of HEC familiarity with the underlying MMR technology. HEC began collaborating with Ultra Safe Nuclear Corporation ("USNC") and the Korea Atomic Energy Research Institute ("KAERI") on high-temperature gas-cooled reactor and MMR technology in 2012, and later supported MMR engineering and procurement activities, including support for a specific opportunity in Canada. NANO Nuclear subsequently acquired USNC's MMR technology in 2025 and now advances the system as the KRONOS MMR**™**Energy System. NANO Nuclear believes this history provides valuable continuity and institutional familiarity with the technology as KRONOS advances through licensing, project execution and toward future deployment.

"NANO Nuclear is deliberately assembling the industrial capabilities required to move advanced nuclear technology from design into repeatable deployment.” said Jay Yu, Founder and Chairman of NANO Nuclear Energy. “Our objective is not simply to develop an advanced microreactor; it is to build the broader platform around it. This includes engineering, manufacturing, fuel, transportation, project execution and the necessary supply chain that can support real projects at scale. Hyundai Engineering brings project-delivery capabilities that can become increasingly valuable as the KRONOS MMR™ system advances from design to regulatory licensing and into construction and ultimate commercialization."

"The next phase of advanced nuclear will be defined by execution.” said James Walker, Chief Executive Officer of NANO Nuclear Energy.“As our KRONOS MMR™ system progresses through NRC review, constructability, procurement, logistics, modularization, interfaces and a qualified supply chain become just as important as the reactor design itself. This MOU gives us a framework to bring HEC into that work early, while creating a pathway from the first U. of I. project toward a standardized and repeatable fleet-deployment model."

"This MOU establishes a foundation for cooperation with a promising advanced nuclear developer. By participating in demonstration and first-of-a-kind project opportunities, we aim to build valuable project experience, strengthen our capabilities across the advanced nuclear project lifecycle and continuously identify new business opportunities in the global market." said Woo-Jeong Joo, Chief Executive Officer of Hyundai Engineering.

A Collaboration Designed to Scale Beyond a Single Project

NANO Nuclear and HEC view the U. of I. project as a potential foundation for a broader relationship. The MOU provides a framework to evaluate future NANO Nuclear projects in the United States, including manufacturing and deployment activities, and to explore ways in which Korean and U.S. industrial capabilities can be combined to support localization, supplier development, project financing and future fleet execution.

The parties may also evaluate future conventional balance-of-plant and infrastructure support for industrial heat, hydrogen, desalination, maritime and other applications. Any future project scope, fabrication activity or commercial award will remain subject to applicable regulatory, quality, export-control, procurement and commercial requirements and to separately executed definitive agreements.

The MOU is non-exclusive and does not itself award any specific work package or commit either party to funding or construction. It establishes the commercial and technical framework through which defined scopes can be evaluated and, where appropriate, advanced under future contracts.

About Hyundai Engineering Co., Ltd.

Hyundai Engineering Co., Ltd. is a Republic of Korea engineering and construction company with capabilities spanning engineering, procurement, construction, project management, supply chain, modularization, logistics and complex industrial-project execution. Under the MOU with NANO Nuclear, HEC will evaluate how those capabilities may support the UIUC KRONOS MMR™ project and potential future NANO Nuclear manufacturing and deployment activities.

About NANO Nuclear Energy, Inc.

NANO Nuclear Energy Inc. (NASDAQ: NNE) is a North American advanced technology-driven nuclear energy company seeking to become a commercially focused, diversified and vertically integrated company across five business lines: (i) cutting-edge portable and other microreactor technologies, (ii) nuclear fuel supply chain, (iii) nuclear fuel transportation, (iv) nuclear applications for space and (v) nuclear industry consulting services.

Led by a world-class nuclear engineering team, NANO Nuclear's reactor products in development include the proprietary KRONOS MMR™ Energy System, a stationary high-temperature gas-cooled reactor whose proposed deployment at UIUC is the subject of a construction permit application currently under NRC review; the ZEUS™ system, a portable solid-core battery reactor; and the space-focused, portable LOKI MMR™ system, each representing advanced developments in clean-energy solutions that are portable, on-demand capable, advanced nuclear microreactors.

Advanced Fuel Transportation Inc. (AFT), a NANO Nuclear subsidiary, bolstered by the May 2026 acquisition of Secured Transportation Services (STS), provides nuclear engineering and materials transport services in the U.S. and globally. Through NANO Nuclear, AFT is the exclusive licensee of a patented high-capacity HALEU fuel transportation basket developed by three major U.S. national laboratories and funded by the U.S. Department of Energy.

HALEU Energy Fuel Inc. (HEF), a NANO Nuclear subsidiary, is focused on the future development of a domestic source for a High-Assay, Low-Enriched Uranium (HALEU) fuel fabrication pipeline for NANO Nuclear's own microreactors as well as the broader advanced nuclear reactor industry.

NANO Nuclear Space Inc. (NNS), a NANO Nuclear subsidiary, is exploring the potential commercial applications of NANO Nuclear's developing micronuclear reactor technology in space, including power systems for extraterrestrial projects and human-sustaining environments and potentially propulsion technology for long-haul space missions.

For more corporate information please visit: https://NanoNuclearEnergy.com/

For further NANO Nuclear information, please contact: Email: [email protected] Business Tel: (212) 634-9206

PLEASE FOLLOW OUR SOCIAL MEDIA PAGES HERE: NANO Nuclear Energy LINKEDIN NANO Nuclear Energy YOUTUBE NANO Nuclear Energy X PLATFORM

Cautionary Note Regarding Forward Looking Statements

This news release and statements of NANO Nuclear's management and collaborators in connection with this news release contain or may contain "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. In this context, forward-looking statements mean statements related to future events, which may impact our expected future business and financial performance, and often contain words such as "expects", "anticipates", "intends", "explore", "plans", "aim", "goal", "believes", "potential", "future", "will", "should", "could", "would" or "may" or derivations of these words and other words of similar meaning about the future. In this press release, forward-looking statements include those relating to the anticipated potential benefits to NANO Nuclear of the MOU with Hyundai Engineering & Construction described herein (which MOU only represents a non-binding framework for exploration), as well as statements regarding potential future work scopes or definitive agreements, the timing and outcome of NRC review of the U. of I. KRONOS MMR™ project, future manufacturing and fleet-deployment activities, and NANO Nuclear's operational and commercialization plans and goals generally. These and other forward-looking statements are based on information available to us as of the date of this news release and represent management's current views and assumptions. Forward-looking statements are not guarantees of future performance, events or results and involve significant known and unknown risks, uncertainties and other factors, which may be beyond our control. For NANO Nuclear, particular risks and uncertainties that could cause our actual future results to differ materially from those expressed in our forward-looking statements include but are not limited to: (i) risks related to our U.S. Department of Energy ("DOE"), U.S. Nuclear Regulatory Commission ("NRC"), Canadian Nuclear Safety Commission ("CNSC") or related state or other U.S. or non-U.S. nuclear licensing submissions; (ii) risks related to the development of new or advanced technology and the acquisition or integration of complementary technology or businesses, including difficulties with design and testing, cost overruns, regulatory delays, integration issues and the development of competitive technology; (iii) our ability to obtain and maintain key vendor, technology, project, financing and customer relationships and the significant funding necessary to execute on our business plan; (iv) uncertainty regarding our ability to technologically develop, license, manufacture and commercially deploy a competitive advanced nuclear reactor or other technology in the timelines we anticipate, if ever; (v) risks related to government regulation, policy, public procurement, export controls, supply-chain requirements and licensing requirements; and (vi) similar risks and uncertainties associated with operating a developing business in a highly regulated, competitive and rapidly evolving industry, including that our plans may change and we may use our cash on hand faster or in different ways than anticipated as our business requires. Readers are cautioned not to place undue reliance on these forward-looking statements, which apply only as of the date of this news release. These factors may not constitute all factors that could cause actual results to differ from those discussed in any forward-looking statement, and NANO Nuclear therefore encourages investors to review other factors that may affect future results in its filings with the SEC, which are available for review at www.sec.gov and at https://ir.nanonuclearenergy.com/financial-information/sec-filings. Accordingly, forward-looking statements should not be relied upon as a predictor of actual results. We do not undertake to update our forward-looking statements to reflect events or circumstances that may arise after the date of this news release, except as required by law.

Prompts

Nano Nuclear Energy Inc. (ticker NNE), listed in United States.

ETFs Holding Nano Nuclear Energy Inc.

ETF Weight in ETF Shares Market value As of
AIPO 0.27% 192,078 $ 2.13M Nov 13, 2026
CCSO 0.05% 2,062 $ 22.146K Nov 17, 2026
AVSC 0.01% 22,425 $ 240.845K Nov 16, 2026